| Company/Division name | Unilife |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2011 |
| Offshore, work was done: | Outsourced |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 32 |
| Country(ies) from which reshored: | China |
| City reshored to: | York |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment/Supplies |
| Product(s) reshored | Prefilled syringes with retractable needles |
| What non-domestic negative factors made offshoring less attractive? | Regulatory compliance |
